Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum‐endemic sub‐Saharan Africa

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Tropical medicine & international health

• Publication date

  2003-06-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1046/j.1365-3156.2003.01066.xPMID 12791054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Severe falciparum malaria

  2004cited by this paper
• Amodiaquine for treating malaria.

  2003cited by this paper
• Artemether-lumefantrine for treating uncomplicated falciparum malaria.

  2003cited by this paper
• Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 6th Edition

  2003influential reference
• Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.

  2002cited by this paper
• Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants.

  2002cited by this paper
• The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria.

  2002cited by this paper
• Interaction Trial between Artemether‐Lumefantrine (Riamet®) and Quinine in Healthy Subjects

  2002cited by this paper
• Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.

  2002cited by this paper
• Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy.

  2001cited by this paper
• The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy.

  2001influential reference
• Folic acid antagonists during pregnancy and risk of birth defects.

  2001cited by this paper
• Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.

  2001influential reference
• The burden of malaria in pregnancy in malaria-endemic areas.

  2001influential reference
• Monitoring antimalarial drug resistance (report of a WHO Consultation)

  2001cited by this paper
• A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.

  2001cited by this paper
• A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania.

  2001influential reference
• Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.

  2001cited by this paper
• Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum.

  2001cited by this paper
• Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99.

  2000cited by this paper
• The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin

  2000cited by this paper
• Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.

  2000cited by this paper
• Vertical transmission of HIV-1 infection.

  2000cited by this paper
• Increased susceptibility to malaria during the early postpartum period.

  2000cited by this paper
• Folic acid antagonists during pregnancy and the risk of birth defects.

  2000cited by this paper
• Treatment of Sexually Transmitted Bacterial Diseases in Pregnant Women

  2000cited by this paper
• Rosette formation by clinical isolates of Plasmodium falciparum in serum-free medium.

  2000cited by this paper
• Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial.

  2000cited by this paper
• Pharmacokinetic interaction trial between co-artemether and mefloquine.

  2000cited by this paper
• Doxycycline use for rickettsial disease in pediatric patients.

  2000cited by this paper
• Malaria chemoprophylaxis with tafenoquine: a randomised study.

  2000cited by this paper
• Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.

  2000cited by this paper
• Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy.

  2000influential reference
• Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.

  1999influential reference
• Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.

  1999influential reference
• The effects of mefloquine treatment in pregnancy.

  1999influential reference
• Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.

  1999cited by this paper
• Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.

  1999cited by this paper
• Making malaria-treatment policy in the face of drug resistance.

  1999cited by this paper
• No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.

  1999cited by this paper
• Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa.

  1999cited by this paper
• Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia.

  1999cited by this paper
• Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa.

  1999cited by this paper
• Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in Zambia.

  1999cited by this paper
• Effects of Plasmodium vivax malaria in pregnancy.

  1999influential reference
• Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery.

  1999cited by this paper
• Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.

  1999cited by this paper
• A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.

  1999cited by this paper
• Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand.

  1999influential reference
• Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.

  1999influential reference
• Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.

  1999cited by this paper
• A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.

  1998cited by this paper
• Chlamydia in Pregnancy: A Randomized Trial of Azithromycin and Erythromycin

  1998cited by this paper
• Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.

  1998influential reference
• Artemisinin derivatives in the treatment of falciparum malaria in pregnancy.

  1998cited by this paper
• Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review.

  1998cited by this paper
• Effect of chloroquine prophylaxis during pregnancy on maternal haematocrit.

  1998cited by this paper
• Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy.

  1998cited by this paper
• An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi

  1998influential reference
• Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya.

  1998cited by this paper
• Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.

  1998influential reference
• Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.

  1998cited by this paper
• Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

  1998influential reference
• An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.

  1998cited by this paper
• Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.

  1998cited by this paper
• Doxycycline and staining of permanent teeth.

  1998cited by this paper
• Antibiotic selection in obstetric patients.

  1997cited by this paper
• Seasonality, malaria, and impact of prophylaxis in a West African village. II. Effect on birthweight.

  1997cited by this paper
• Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.

  1997cited by this paper
• Mefloquine to prevent malaria: a systematic review of trials

  1997cited by this paper
• The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen.

  1997cited by this paper
• Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria

  1997influential reference
• Seasonality, malaria, and impact of prophylaxis in a West African village I. Effect of anemia in pregnancy.

  1997cited by this paper
• Atovaquone and proguanil for the treatment of malaria in Brazil.

  1997cited by this paper
• Systematic review of amodiaquine treatment in uncomplicated malaria.

  1996cited by this paper
• The Safety of Antimalarial Drugs in Pregnancy

  1996cited by this paper
• Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.

  1996cited by this paper
• Atovaquone and proguanil for Plasmodium falciparum malaria.

  1996influential reference
• The problem of malaria and malaria control in pregnancy in sub-Saharan Africa.

  1996cited by this paper
• Microencapsulation of chloroquine diphosphate by Eudragit RS100.

  1996cited by this paper
• Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria.

  1996cited by this paper
• Developing effective strategies for malaria prevention programs for pregnant African women.

  1996cited by this paper
• Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.

  1996cited by this paper
• Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: chloroquine and sulfadoxine-pyrimethamine.

  1996cited by this paper
• Sensitivity of Plasmodium falciparum to reduced dose of mefloquine in pregnant women in Nigeria.

  1996influential reference
• The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.

  1996cited by this paper
• The effect of placental malaria infection on perinatal mortality in rural Malawi.

  1996cited by this paper
• A decade of progress in malaria policy and program development in Malawi; 1984-1993

  1995cited by this paper
• Increase of birth weight following chloroquine chemoprophylaxis during the first pregnancy: results of a randomized trial in Cameroon.

  1995cited by this paper
• Cardiac complications of halofantrine: a prospective study of 20 patients.

  1995cited by this paper
• Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria.

  1994influential reference
• The Transfer of Drugs and Other Chemicals Into Human Milk

  1994cited by this paper
• Clinical trials of artemisinin and its derivatives in the treatment of malaria in China.

  1994cited by this paper
• Malaria and childbearing women in Malawi: knowledge, attitudes and practices.

  1994cited by this paper
• The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.

  1994cited by this paper
• Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae.

  1994influential reference
• Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study.

  1994influential reference
• Azithromycin and Erythromycin in the Treatment of Cervical Chlamydial Infection During Pregnancy

  1994cited by this paper
• The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women.

  1994cited by this paper
• Malaria chemoprophylaxis compliance in pregnant women: a cost-effectiveness analysis of alternative interventions.

  1993cited by this paper

• British HIV Association guidelines on the management of opportunistic infection in people living with HIV: Considerations in pregnancy 2024

  2024cites this paper
• Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus on birth outcomes in Botswana

  2022cites this paper
• for the Prevention and Treatment of Opportunistic Infections in Adults and

  2020cites this paper
• The Impact of Nutrition-Specific and Nutrition-Sensitive Interventions on Hemoglobin Concentrations and Anemia: A Meta-review of Systematic Reviews

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• Association of Directly Observed Prophylaxis with Sulfadoxine-Pyrimethamine for Prevention of Mother-to-Fetus Transmission of Malaria, Kananga, Democratic Republic of the Congo

  2020cites this paper
• Malaria in Pregnancy: an overview

  2020cites this paper
• Elucidation of Malaria on Metabolic Activities During Pregnancy

  2019cites this paper
• Secondary prophylaxis of toxoplasmosis in pregnancy in an HIV-positive woman

  2018cites this paper
• Common infectious diseases in pregnancy and its impact on perinatal outcome: A prospective study

  2018cites this paper
• Factors affecting the uptake of malaria prevention strategies among pregnant women in Nigeria: evidence from 2013 Nigeria demographic and health survey

  2018cites this paper
• O paradigma da infecção por Plasmodium falciparum em mulheres grávidas seropositivas para HIV: a prevenção da transmissão vertical e a infecção congénita

  2017cites this paper
• Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study

  2016cites this paper
• Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superi

  2015cites this paper
• Malaria and helminth co-infections in school and pre-school children in Magu district, Tanzania

  2015cites this paper
• Neuropsychiatric adverse events during prophylaxis against malaria by using mefloquine before traveling

  2015cites this paper
• African women in malaria endemic areas get pregnant and are at risk of infection with

  2015cites this paper
• Plasmodium falciparum parasitaemia among booked parturients who received two doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) in a tertiary health facility Southeast Nigeria

  2015cites this paper
• APPRAISAL OF THE EFFICACY OF SP-IPTP IN AMINU KANO TEACHING HOSPITAL – IMPACT ON MATERNAL ANAEMIA , MALARIA PARASITAEMIA AND CLINICAL MALARIA IN PREGNANCY

  2015cites this paper
• An evaluation of intermittent preventive treatment of malaria during pregnancy in four Health Centres in Lusaka District

  2015cites this paper
• Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention

  2014cites this paper
• Appraisal of the Efficacy of Sp-Iptp at Aminu Kano Teaching Hospital-Impact on Maternal Anaemia, Malaria Parasitaemia and Clinical Malaria

  2014cites this paper
• Anti-infective Agents

  2014cites this paper
• Mefloquine safety and tolerability in pregnancy: a systematic literature review

  2014cites this paper
• Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d’Ivoire five years after its implementation

  2014cites this paper
• A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia

  2013cites this paper
• The effect of falciparum malaria prevalence on the effectiveness of intermittent preventive treatment with Sulfadoxine-Pyrimethamine during pregnancy in reducing low birth weight in southern Mozambique

  2013cites this paper
• Malaria in Malawi

  2013influential citation
• INFLUENCE OF HEALTH SYSTEMS IN MALARIA CASE MANAGEMENT AS PART OF MALARIA CONTROL IN

  2013cites this paper
• Mefloquine Gap Junction Blockade and Risk of Pregnancy Loss1

  2012cites this paper
• Pregnancy and Fetal Outcomes After Exposure to Mefloquine in the Pre- and Periconception Period and During Pregnancy

  2012cites this paper
• The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy

  2012cites this paper
• Proguanil versus Sulphadoxine-Pyrimethamine for Malaria Chemoprophylaxis in Pregnancy: A Randomised Controlled Trial

  2012cites this paper
• Artemether-Lumefantrine: An Option for Malaria

  2012cites this paper
• Polymorphism of Plasmodium Falciparum Dihydrofolate Reductase and Dihydropteroate Synthase Genes among Pregnant Women with Falciparum Malaria in Banjar District, South Kalimantan Province, Indonesia

  2012cites this paper
• Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries.

  2012cites this paper
• In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum

  2011cites this paper
• Evaluating Health Workers' Potential Resistance to New Interventions: A Role for Discrete Choice Experiments

  2011cites this paper
• Interventions, surveillance and monitoring of malaria in pregnancy in rural southern Malawi

  2011cites this paper
• Scaling Up of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulphadoxine–Pyrimethamine: Prospects and Challenges

  2011cites this paper
• Patterns of anti-malarial drug treatment among pregnant women in Uganda

  2011cites this paper
• The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of ashanti region, Ghana

  2011cites this paper
• Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.

  2011cites this paper
• Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: Provider Knowledge and Acceptability

  2011cites this paper
• CHAPTER 2 – Neonatal Infections: A Global Perspective

  2011cites this paper
• Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

  2011cites this paper
• Sulfadoxine–pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC)

  2011cites this paper
• The Use of Sulpiiadoxine Pyrimethamine as Intermitten Preventive Treatment For Malaria In Pregnancy; A Study at the Kpeshie Sub Metropolis

  2010cites this paper
• Pharmaco-epidemiology of artemisinin-based combination therapy in the context of impact evaluation of artemether-lumefantrine on malaria morbidity and mortality during programmatic implementation in rural Tanzania

  2010cites this paper
• Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability

  2010cites this paper
• Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon

  2010cites this paper
• Supporting capacity for research on malaria in Africa

  2010cites this paper
• Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: A Randomised Controlled Non-Inferiority Trial

  2010cites this paper
• Evaluation of malaria prevention strategies during pregnancy in Ndola, Zambia

  2010influential citation
• Availability and utilization of malaria prevention strategies in pregnancy in eastern India

  2010cites this paper
• Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy

  2010cites this paper
• The position of mefloquine as a 21st century malaria chemoprophylaxis

  2010cites this paper
• Pregnancy health status of sub-Saharan refugee women who have resettled in developed countries: a review of the literature.

  2010cites this paper
• A strategic framework for malaria prevention and control during pregnancy in the African region

  2010cites this paper
• Intermittent preventive treatment against malaria: an update

  2010cites this paper
• Observierte vs. nicht-observierte Therapie der unkomplizierten Malaria tropica mit Artesunat und Amodiaquin bei Kleinkindern in Lambaréné, Gabun

  2009cites this paper
• Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents.

  2009cites this paper
• Malaria in der Schwangerschaft vor und nach nationaler Einführung des Intermittent Preventive Treatment in pregnancy (IPTp) in Gabun

  2009cites this paper
• Evaluation of the use of sulfadoxine-pyrimethamine (SP) intermittent treatment (IPT) to prevent malaria during pregnancy in Ndola, Zambia.

  2009cites this paper
• Severe Embryotoxicity of Artemisinin Derivatives in Experimental Animals, but Possibly Safe in Pregnant Women

  2009cites this paper
• Treatment and prevention of malaria in pregnancy and newborn

  2008cites this paper
• Dapsone, danazol, and intrapartum splenectomy in refractory ITP complicating pregnancy.

  2008cites this paper
• Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy

  2008cites this paper
• Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research.

  2008cites this paper
• Treating malaria in pregnancy in developing countries: priorities in clinical research and drug development

  2008cites this paper
• Aus der Medizinischen Universitund Poliklinik (Department) T¨ ubingen

  2008cites this paper
• Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.

  2008cites this paper
• Impact comparatif de trois schémas de prévention du paludisme pendant la grossesse sur l’anémie maternelle, associée à l’infection palustre au Burkina Faso

  2008cites this paper
• Effectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malaria.

  2008cites this paper
• Malaria in pregnancy: a literature review.

  2008cites this paper
• The health impact of polyparasitism in humans: are we under-estimating the burden of parasitic diseases?

  2008cites this paper
• [Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso].

  2008cites this paper
• Effects of maternal multiple micronutrient supplementation on fetal growth: a double-blind randomized controlled trial in rural Burkina Faso.

  2008cites this paper
• A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.

  2008cites this paper
• Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.

  2007cites this paper
• Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas

  2007cites this paper
• Malaria in pregnancy: linking immunity and pathogenesis to prevention.

  2007cites this paper
• Reducing the burden of malaria in pregnancy by preventive strategies.

  2007cites this paper
• Perception and practice of malaria prophylaxis in pregnancy among health care providers in Ibadan.

  2007cites this paper
• Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed?

  2007cites this paper
• Malaria burden among pregnant women living in the rural district of Boromo, Burkina Faso.

  2007cites this paper
• The safety of amodiaquine use in pregnant women

  2007cites this paper
• Tafenoquine: a promising new antimalarial agent

  2007cites this paper
• Anti-infective agents

  2007cites this paper
• Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.

  2007cites this paper
• Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda

  2007cites this paper
• The safety of artemisinins during pregnancy: a pressing question

  2007cites this paper
• Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.

  2006cites this paper
• Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings.

  2006cites this paper
• Perceptions on use of sulfadoxine-pyrimethamine in pregnancy and the policy implications for malaria control in Uganda.

  2006cites this paper
• Neonatal Infections: A Global Perspective

  2006cites this paper
• The pregnant traveller.

  2006cites this paper
• Conquering Malaria

  2006cites this paper
• Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.

  2006cites this paper
• Treatment and prevention of malaria in pregnancy: opportunities and challenges

  2006cites this paper